Research articleTrends in Care Practices and Outcomes Among Medicare Beneficiaries with Diabetes
Introduction
The economic cost of diabetes increased from $98 billion in 1997 to $132 billion in 2002,1, 2 and has continued to increase in subsequent years. The disease has also become more prevalent. Both developments have made the tracking of complications and services received by individuals with diabetes imperative for informed policymaking.
Understanding these trends is especially relevant to Medicare because the Medicare population bears a disproportionate burden of the disease in both prevalence and cost. An estimated 20% of elderly individuals has diabetes compared with 5% of the general population.3, 4 Elderly people living with diabetes incur healthcare expenditures ≥50% higher than those without the disease.5, 6
Much work has shown recent improvements in the quality of diabetes care for Medicare beneficiaries (fee for service [FFS]7 and managed care8) as well as other groups,9, 10, 11 although further improvement is necessary to achieve targets outlined in Healthy People 2010.12 These quality indicators emphasize types of preventive care, such as annual HbA1c testing or biennial dilated eye examinations, that may reduce the incidence or delay the onset of complications associated with diabetes. However, these studies provide only a partial picture of the burden of diabetes since they do not analyze trends in the complications that contribute to the high cost of the disease.
Other work specific to the Medicare population has focused on late-stage outcomes by concentrating on death certificates, hospital discharges, and excess diabetes-associated mortality among the elderly.13, 14, 15 Although not focused on the Medicare population, the Diabetes Surveillance System16 provides self-reported preventive care and complication rates for the general population of individuals with diabetes, as well as by different subgroups (including age).
Consequently, little has been done to assemble an overall picture of trends in diabetes care for Medicare beneficiaries based on indicators such as preventive services and the broad array of conditions complicating the disease.
The purpose of this article is to develop such a picture by analyzing rates of preventive care practices and acute- and long-term complications among Medicare beneficiaries with diabetes over a 10-year period. The article also examines whether there is evidence that quality of care has improved, and whether racial or other subgroup differences exist. Results of the analysis will provide policymakers, researchers, and practitioners with information on trends in the quality of diabetes care and on potential areas of concern—such as specific complications or subgroup conditions and care disparities—where resources may be most beneficially directed.
Section snippets
Study Sample
The study sample comes from the Medicare Quality Monitoring System (MQMS), which the Centers for Medicare & Medicaid Services (CMS) maintains to monitor the quality of care delivered to Medicare FFS beneficiaries. MQMS uses Medicare administrative data to track national and state trends, patterns, and variations in the use of health care and outcomes of that care, preventable hospitalizations, and patient safety. Diabetes is among the five conditions (including acute myocardial infarction
Results
The number of Medicare beneficiaries with diagnosed diabetes (without ESRD) nationwide rose by 52% from 1992 through 2001, from an estimated 2,944,340 beneficiaries to 4,481,100. The estimated prevalence of diabetes among Medicare beneficiaries also increased over the period, from 9.2% in 1992 to 14.2% in 2001.
Discussion
This analysis demonstrates significant improvement in the rate of preventive care practices. In addition, rates of both short-term and some of the most serious long-term complications have declined. Yet, this progress toward improving the overall quality of diabetes care is tempered by rising rates of other complications.
The findings show progress toward meeting Healthy People 2010 targets for HbA1c testing, lower-extremity amputations, and eye examinations.12 The estimated rate of HbA1c
References (32)
- et al.
Economic impact of diabetes mellitus in the elderly
Clin Geriatr Med
(1990) Economic costs of diabetes in the U.S. in 2002
Diabetes Care
(2003)Economic consequences of diabetes mellitus in the U.S. in 1997
Diabetes Care
(1998)- (1999)
- et al.
Diabetes trends in the U.S.1990–1998
Diabetes Care
(2000) - et al.
Predicting expenditures for Medicare beneficiaries with diabetesa prospective cohort study from 1994 to 1996
Diabetes Care
(1999) - et al.
Change in the quality of care delivered to Medicare beneficiaries, 1998–1999 to 2000–2001
JAMA
(2003) - et al.
HEDIS performance measures in Medicare managed care
Health Care Finance Rev
(2001) - et al.
Effect of transformation of the Veterans Affairs health care system on the quality of care
N Engl J Med
(2003) - et al.
Preventive-care practices among persons with diabetes—United States, 1995 and 2001
MMWR Morb Mortal Wkly Rep
(2002)
Thirty-year trends in cardiovascular risk factor levels among US adults with diabetes
Am J Epidemiol
Diabetes-related morbidity and mortality in a national sample of U.S. elders
Diabetes Care
Trends in diabetes and diabetic complications1980–1987
Diabetes Care
Heart failure prevalence, incidence and mortality in the elderly with diabetes
Diabetes Care
Cited by (49)
Diabetic foot ulcers: Epidemiology and the role of multidisciplinary care teams
2021, Seminars in Vascular SurgeryDeep learning algorithms for detection of diabetic retinopathy in retinal fundus photographs: A systematic review and meta-analysis
2020, Computer Methods and Programs in BiomedicineCitation Excerpt :The American Diabetes Association (ADA) recommends screening for retinopathy for type 1 diabetic patients within three to five years after onset while type 2 diabetic need to screen one year after onset [11]. The subsequent examination should be carried out every six months to the one-year basis of severity of DR. Despite having standard guidelines for screening, approximately 30 to 50 percent of patients with DM are still not getting benefits from these recommendations [12]. Recently, multiple studies investigated the use of DL systems in automated detection of DR and achieved excellent diagnostic performance in terms of high sensitivity and specificity.
Characteristics Associated with Adherence to Annual Dilated Eye Examinations among US Patients with Diagnosed Diabetes
2019, OphthalmologyCitation Excerpt :Previous studies of Medicare beneficiaries with diabetes indicated minimal to no change in adherence to eye exams.25,26 Although Kuo et al25 observed an 8.3% increase in adherence from 1992 to 2001, the number of patients with diabetes in their population doubled over this time period, which accounts for at least part of the improvement in adherence rates. More recent studies do not report on changes in adherence rate over time or their study population is observed for less than 5-year follow-up periods, and the observed trends within a short timeframe are less meaningful.12
Trends in the care and outcomes of medicare beneficiaries with type 2 diabetes, 2002-2011
2016, Endocrine PracticeDeliberations about the functional benefits and complications of partial foot amputation: Do we pay heed to the purported benefits at the expense of minimizing complications?
2013, Archives of Physical Medicine and RehabilitationRacial and ethnic disparities in diabetes complications in the northeastern United States: The role of socioeconomic status
2013, Journal of the National Medical Association
When the analysis was conducted, Kuo and Fleming were affiliated with Mathematica Policy Research, and the Centers for Medicare & Medicaid Services, respectively.